Newly diagnosed diabetes in patients with mild to moderate COVID-19

Diabetes Metab Syndr. 2021 Mar-Apr;15(2):569-571. doi: 10.1016/j.dsx.2021.02.034. Epub 2021 Mar 3.

Abstract

Background and aims: We aimed to study newly diagnosed diabetes in patients with mild to moderate COVID-19.

Methods: This was a retrospective cohort study of COVID-19 patients who were admitted to a tertiary care hospital in India from May to October 2020.

Results: Of 102 patients, 21 (20.6%) had newly diagnosed diabetes on admission. Of which, four (19.0%) had marked hyperglycemia with no ketosis or ketoacidosis.

Conclusion: In this study of patients with mild to moderate COVID-19, newly diagnosed diabetes and marked hyperglycemia in those with newly diagnosed diabetes were common.

Keywords: COVID-19; Diabetes; Hyperglycemia; New-onset diabetes; Newly diagnosed diabetes.

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Blood Glucose / metabolism*
  • COVID-19 / complications
  • COVID-19 / physiopathology*
  • COVID-19 / therapy
  • Cohort Studies
  • Dexamethasone / therapeutic use
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / diagnosis*
  • Diabetes Mellitus, Type 2 / metabolism
  • Female
  • Glucocorticoids / therapeutic use
  • Glycated Hemoglobin / metabolism*
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • India
  • Male
  • Middle Aged
  • Oxygen Inhalation Therapy
  • Retrospective Studies
  • SARS-CoV-2
  • Severity of Illness Index

Substances

  • Anticoagulants
  • Blood Glucose
  • Glucocorticoids
  • Glycated Hemoglobin A
  • Heparin, Low-Molecular-Weight
  • hemoglobin A1c protein, human
  • Dexamethasone